Therapeutic value of tafamidis in patients with wild-type transthyretin amyloidosis (ATTRwt) with cardiomyopathy based on cardiovascular magnetic resonance (CMR) imaging

26 August 2022 (08:00 - 19:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Bishwas Chamling

University Hospital of Greifswald, Greifswald (Germany)

7 More presentations in this session

Presentation thumbnail

Manganese enhanced magnetic resonance imaging in type 1 and type 2 diabetes mellitus

Doctor S. Joshi (Edinburgh, GB)

Abstract Slides

Presentation thumbnail

Subclinical myocardial injury in ATTR-related familial amyloid polyneuropathy patients without clinical signs of cardiomyopathy

Doctor C. Martins (Campinas, BR)

Abstract Slides

Presentation thumbnail

Comparing the findings and diagnostic accuracy of cardiac magnetic resonance imaging in patients with biopsy confirmed acute myocarditis presenting with infarct-like and heart failure symptoms

Doctor K. Hassan (Mossel Bay, ZA)

Abstract Slides

Presentation thumbnail

Prognostic role of cardiac magnetic resonance in left ventricular non compaction

Miss A. Romero Valero (Elche, ES)

Abstract Slides

Presentation thumbnail

Coexistent diabetes is associated with the presence of adverse phenotypic features in patients with hypertrophic cardiomyopathy

Doctor N. Jex (Leeds, GB)

Abstract Slides

Access the full session

Session thumbnail

Cardiac magnetic resonance in myocardial disease

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

You may be interested in

Congress Presentation

Magnetic resonance imaging is the way to go for risk assessment

Congress Presentation

Cardiac magnetic resonance imaging in the work-up and management of cardiac amyloidosis

Congress Presentation

CMR for inflammation, oedema, and the pericardium

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources